But the child's parents have decided to forego long-term monitoring by researchers.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Therapeutic Options in Hereditary Optic Neuropathies
Drugs Open Access 07 November 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Zhang, J. et al. Reprod. Biomed. Online 34, 361-368 (2017).
Wallace, D. C. & Chalkia, D. Cold Spring Harb. Perspect. Biol. 5, a021220 (2013).
Alikani, M., Fauser, B. C. J., Garcia-Valesco, J. A., Simpson, J. L. & Johnson, M. H. Reprod. Biomed. Online 34, 333–368 (2017).
Related links
Related links
Related links in Nature Research
Historic decision allows UK researchers to trial ‘three person’ babies 2016-Dec-15
Reports of ‘three-parent babies’ multiply 2016-Oct-19
‘Three-parent baby’ claim raises hopes — and ethical concerns 2016-Sep-28
Three-person embryos may fail to vanquish mutant mitochondria 2016-May-19
The hidden risks for ‘three-person’ babies 2015-Sep-23
Reproductive medicine: The power of three 2014-May-21
Related external links
Rights and permissions
About this article
Cite this article
Reardon, S. Genetic details of controversial 'three-parent baby' revealed. Nature 544, 17–18 (2017). https://doi.org/10.1038/nature.2017.21761
Published:
Issue date:
DOI: https://doi.org/10.1038/nature.2017.21761
This article is cited by
-
Aneuploidy in mammalian oocytes and the impact of maternal ageing
Nature Reviews Molecular Cell Biology (2023)
-
Therapeutic Options in Hereditary Optic Neuropathies
Drugs (2021)
